A strong correction of high EWSAT1 expression in tumors with poor survival was confirmed in 108 NPC samples, revealing that EWSAT1 expression levels could be as a useful prognostic biomarker to help identify patients who are at a higher risk of NPC progression. The gene discussed is EWSAT1; the disease is nasopharyngeal carcinoma.